The effect of medetomidine-ketamine anesthesia on hemodynamic parameters during hemorrhagic shock in minipigs

Physiological Research

Volumn 59, Issue 5, 2010, Pages 703-710

  Brezina, A ^a   Drabek, T ^b   Riha, H ^a,c   Schreiberova, J ^d   Hess, L ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^d UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Alpha2 agonists; Hemorrhagic shock; Ketamine; Propofol; Remifentanil

Indexed keywords

ANESTHETIC AGENT; HYPNOTIC SEDATIVE AGENT; KETAMINE; MEDETOMIDINE; PIPERIDINE DERIVATIVE; PROPOFOL; REMIFENTANIL;

ANESTHESIA; ANIMAL; ARTICLE; BLOOD PRESSURE; BLOOD VOLUME; COMPARATIVE STUDY; DRUG EFFECT; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HEMORRHAGIC SHOCK; METHODOLOGY; PATHOPHYSIOLOGY;

ANESTHESIA; ANESTHETICS, DISSOCIATIVE; ANIMALS; BLOOD PRESSURE; BLOOD VOLUME; CARDIAC OUTPUT; HEART RATE; HEMODYNAMICS; HYPNOTICS AND SEDATIVES; KETAMINE; MEDETOMIDINE; PIPERIDINES; PROPOFOL; SHOCK, HEMORRHAGIC;

EID: 78649756465     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. ADAMS P, GELMAN S, REVES JG, GREENBLATT DJ, ALVIS JM, BRADLEY E: Midazolam pharmacodynamics and pharmacokinetics during acute hypovolemia. Anesthesiology 63: 140-146, 1985.
2. ALAM HB, RHEE P: New developments in fluid resuscitation. Surg Clin North Am 87: 55-72, 2007.
3. BARTON KP, MUNOZ R, MORELL VO, CHRYSOSTOMOU C: Dexmedetomidine as the primary sedative during invasive procedures in infants and toddlers with congenital heart disease. Pediatr Crit Care Med 9: 612-615, 2008.
4. BOND AC, DAVIES CK: Ketamine and pancuronium for the shocked patient. Anaesthesia 29: 59-62, 1974.
5. CAULKETT NA, CATTET MR, CAULKETT JM, POLISCHUK SC: Comparative physiologic effects of telazol, medetomidine-ketamine, and medetomidine-telazol in captive polar bears (Ursus maritimus). J Zoo Wildl Med 30: 504-509, 1999.
6. CHASAPAKIS G, KEKIS N, SAKKALIS C, KOLIOS D: Use of ketamine and pancuronium for anesthesia for patients in hemorrhagic shock. Anesth Analg 52: 282-287, 1973.
7. CHIEN S: Role of sympathetic nervous system in surviving acute hemorrhage. Am J Physiol 206: 21-24, 1964.
8. CHRISTIAN CM, NARAGHI M, ADRIANI J: Adverse effects of pancuronium in patients with hemorrhagic shock. South Med J 72: 1113-1115, 1979.
9. CLOSE AS, WAGNER JA, KLOEHN RA Jr, KORY RC: The effect of norepinephrine on survival in experimental acute hemorrhagic hypotension. Surg Forum 8: 22-26, 1957.
10. DIEHL KH, HULL R, MORTON D, PFISTER R, RABEMAMPIANINA Y, SMITH D, VIDAL JM, VAN DE VORSTENBOSCH C: A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 21: 15-23, 2001.
11. HASKINS SC, PATZ JD: Ketamine in hypovolemic dogs. Crit Care Med 18: 625-629, 1990.
12. JALANKA H, SKUTNABB K, DAMSTEN Y: Preliminary results on the use of medetomidine-ketamine combinations in the dog. Acta Vet Scand Suppl 85: 125-127, 1989.
13. JOHNSON KB, KERN SE, HAMBER EA, MCJAMES SW, KOHNSTAMM KM, EGAN TD: Influence of hemorrhagic shock on remifentanil: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology 94: 322-332, 2001.
14. JOHNSON KB, EGAN TD, KERN SE, WHITE JL, MCJAMES SW, SYROID N, WHIDDON D, CHURCH T: The influence of hemorrhagic shock on propofol: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology 99: 409-420, 2003.
15. KAUKINEN S: Effects of antihypertensive medication on the cardiovascular response to ketamine in rats. Acta Anaesthesiol Scand 22: 437-446, 1978.
16. KO JC, FOX SM, MANDSAGER RE: Sedative and cardiorespiratory effects of medetomidine, medetomidinebutorphanol, and medetomidine-ketamine in dogs. J Am Vet Med Assoc 216: 1578-1583, 2000.
17. KURITA T, TAKATA K, MORITA K, MORISHIMA Y, URAOKA M, KATOH T, SATO S: The influence of hemorrhagic shock on the electroencephalographic and immobilizing effects of propofol in a swine model. Anesth Analg 109: 398-404, 2009.
18. LEE CJ, SUBEQ YM, LEE RP, WU WT, HSU BG: Low-dose propofol ameliorates haemorrhagic shock-induced organ damage in conscious rats. Clin Exp Pharmacol Physiol 35: 766-774, 2008.
19. LEE CJ, LEE RP, SUBEQ YM, LEE CC, PENG TC, HSU BG: Propofol protects against hemorrhagic shock-induced organ damage in conscious spontaneously hypertensive rats. Biol Res Nurs 11: 152-162, 2009.
20. LEVANEN J, MAKELA ML, SCHEININ H: Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium. Anesthesiology 82: 1117-1125, 1995.
21. LONGNECKER DE, STURGILL BC: Influence of anesthetic agent on survival following hemorrhage. Anesthesiology 45: 516-521, 1976.
22. MESTER R, EASLEY RB, BRADY KM, CHILSON K, TOBIAS JD: Monitored anesthesia care with a combination of ketamine and dexmedetomidine during cardiac catheterization. Am J Ther 15: 24-30, 2008.
23. MUNRO HM, SLEIGH JW, PAXTON LD: The cardiovascular response to ketamine: the effects of clonidine and lignocaine. Acta Anaesthesiol Scand 37: 75-78, 1993.
24. PENG TC, LIAO KW, LAI HL, CHAO YF, CHANG FM, HARN HJ, LEE RP: The physiological changes of cumulative hemorrhagic shock in conscious rats. J Biomed Sci 13: 385-394, 2006.
25. RIXEN D, RAUM M, HOLZGRAEFE B, SAUERLAND S, NAGELSCHMIDT M, NEUGEBAUER EA: A pig hemorrhagic shock model: oxygen debt and metabolic acidemia as indicators of severity. Shock 16. 239-244, 2001.
26. 2-adrenoceptor agonists? Anesthesiology 76: 873-875, 1992.
27. 2-adrenoceptor agonist: a review of its pharmacodynamic effects. Prog Neuropsychopharmacol Biol Psychiatry 13: 635-651, 1989.
28. 2-agonists related to the clinical use of medetomidine in small animal practice. Can Vet J 44: 885-897, 2003.
29. 2-adrenoceptor agonist-ketamine combinations in captive red wolves. J Am Vet Med Assoc 217: 1366-1371, 2000.
30. STEGMANN GF, JAGO M: Cardiopulmonary effects of medetomidine or midazolam in combination with ketamine or tiletamine/zolazepam for the immobilisation of captive cheetahs (Acinonyx jubatus). J S Afr Vet Assoc 77: 205-209, 2006.
31. TAKIZAWA E, TAKIZAWA D, HIRAOKA H, SAITO S, GOTO F: Disposition and pharmacodynamics of propofol during isovolaemic haemorrhage followed by crystalloid resuscitation in humans. Br J Clin Pharmacol 61: 256-261, 2006.
32. TANAKA M, NISHIKAWA T: Oral clonidine premedication attenuates the hypertensive response to ketamine. Br J Anaesth 73: 758-762, 1994.
33. TOMIZAWA N, TOMITA I, NAKAMURA K, HARA S: A comparative study of medetomidine-butorphanol-ketamine and medetomidine-ketamine anaesthesia in dogs. Zbl Veterinarmed A 44: 189-194, 1997.
34. VAINIO OM, BLOOR BC, KIM C: Cardiovascular effects of a ketamine-medetomidine combination that produces deep sedation in Yucatan mini swine. Lab Anim Sci 42: 582-588, 1992.
35. WIGGERS HC, INGRAHAM RC: Hemorrhagic shock: definition and criteria for its diagnosis. J Clin Invest 25: 30-36, 1946.
36. WIGGERS HC, INGRAHAM RC, DILLE J: Hemorrhagic-hypotension shock in locally anesthetized dogs. Am J Physiol 143: 126-133, 1945.
37. YANG CH, TSAI PS, WANG TY, HUANG CJ: Dexmedetomidine-ketamine combination mitigates acute lung injury in haemorrhagic shock rats. Resuscitation 80: 1204-1210, 2009.
38. YAO L, KUAI J, LIU X, YU D, YANG Y, TAO L, ZENG X, CHAI W: Pretreatment with fentanyl and propofol attenuates myocardial injury in rabbits with acute hemorrhagic shock. J Surg Res 155: 25-31, 2009.